You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沃森生物(300142.SZ):子公司收到一項由巴西專利局頒發的發明專利證書
格隆匯 05-07 19:41

格隆匯 5 月 7日丨沃森生物(300142.SZ)公佈,公司控股子公司上海澤潤生物科技有限公司(“上海澤潤”)於近日收到巴西專利局頒發的發明專利證書,發明名稱為人乳頭狀瘤病毒主要衣殼蛋白L1基因及其用途。

專利要點提供人乳頭瘤病毒主要衣殼蛋白L1基因及其製備方法和用途,包一類密碼子優化的人乳頭瘤病毒主要衣殼蛋白L1編碼基因可在酵母細胞中高效表達L1蛋白,可作為免疫原性大分子,以及其製備方法和用途

上述發明專利應用於上海澤潤相關產品的研發。上述專利獲得授權有利於加強對公司及子公司知識產權的保護,提高公司的核心競爭力。對公司近期生產經營和業績不會產生影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account